TGA warns peptide sellers and influencers of prosecution
The TGA has issued a direct warning to unapproved peptide sellers, influencers and affiliates, stating it will use the full range of enforcement powers including criminal prosecution.
TGA escalates enforcement with direct warning to peptide sellers and influencers
The Therapeutic Goods Administration (TGA) has issued a formal warning to individuals and businesses involved in the unlawful promotion and supply of unapproved peptide products, stating it will deploy the full range of compliance and enforcement powers, including criminal prosecution.
The warning, published 20 July 2026, marks a significant escalation in the TGA’s approach to the online peptide market. While the regulator has previously issued general advisories about the risks of unapproved products, this statement directly targets specific actors in the supply chain: influencers, affiliates, online sellers, and anyone who promotes peptide products through digital channels.
Enforcement toolkit on full display
The TGA outlined the range of actions available to it:
- Warning letters
- Infringement notices (financial penalties)
- Product seizures and forfeiture
- Civil penalties
- Criminal prosecution in serious cases
The regulator stated it is actively identifying and disrupting unlawful activity in the peptide market and is working directly with social media and e-commerce platforms to remove content that breaches platform policies or Australian law.
Targeted warning to influencers and affiliates
In a notable expansion of its enforcement messaging, the TGA explicitly named influencers, affiliates and online sellers as potentially accountable for unlawful advertising.
“Influencers, affiliates, online sellers and anyone else promoting unapproved peptide products may be held accountable for unlawful advertising and should ensure they understand their legal obligations,” the statement read.
The warning covers all forms of digital marketing including websites, online marketplaces, social media posts, and influencer content. Advertising unapproved therapeutic goods to Australian consumers is generally unlawful under the Therapeutic Goods Act.
TGA head: platforms must act
Professor Anthony Lawler, Deputy Secretary of the Department of Health, Disability and Ageing and head of the TGA, said he has written directly to social media and e-commerce platforms about the issue.
“I have written directly to social media and e-commerce platforms, raising the impact and potential consequences of unlawful advertising and sale of unapproved peptide products,” Professor Lawler said.
“We expect platforms to identify and remove unlawful content and take steps to stop it reappearing.”
The direct engagement with platforms signals that the TGA expects technology companies to take a more active role in policing peptide-related content, rather than relying solely on individual enforcement actions.
“If you are unlawfully importing, manufacturing, advertising or supplying unapproved peptide products, expect the TGA to take action,” Professor Lawler said.
“These products can pose serious risks to Australian consumers, and businesses should not assume they can operate outside Australia’s therapeutic goods framework without consequences.”
Border interceptions of unlabelled vials
The TGA also highlighted concerns about product safety, noting it is increasingly intercepting unlabelled vials at the border with no identifying information about their contents or origin.
“Without appropriate quality controls, products may contain the wrong ingredients, be contaminated or fail to meet basic sterility standards, posing significant risks to consumer health and safety,” the statement said.
Professor Robyn Langham, Chief Medical Adviser at the TGA, described the health effects of unapproved peptides as “unpredictable and, in some cases, serious.”
What this means for the market
The July warning represents a clear escalation in both tone and stated intent. While the TGA has been steadily increasing enforcement activity throughout 2026, this statement is the first to specifically name influencers and affiliates as enforcement targets, and to confirm direct engagement with platforms for content removal.
Businesses and individuals involved in the advertising, importation, manufacture, supply or export of unapproved peptide products can expect increased compliance action, the TGA stated. The regulator is also calling on consumers to report suspected unlawful activity or non-compliant advertising.
Sources:
- TGA media release via Mirage News, 20 July 2026: “Unapproved Peptide Sellers Warned”
- news.com.au, 20 July 2026: “Peptide influencers, sellers could be prosecuted under crackdown on black market”
For educational purposes only. This content is informational and reflects publicly reported developments. It is not legal, medical, or regulatory advice. Consult a qualified professional for compliance questions.